Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100052571Phase 4Recruiting
Phase 4, randomised trial of dexmedetomidine in pneumonia (2 arms), sponsored by Jining First People's Hospital. Primary endpoints: Alveolar surfactant protein A and Blood gas analysis. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100052571.